Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome-Reference-Cited by-同舟云学术

Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome

Published:2003-05 Issue:9372 Volume:361 Page:1894-1901
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Harborne Lyndal,Fleming Richard,Lyall Helen,Norman Jane,Sattar Naveed

Publisher

Elsevier BV

Subject

General Medicine

Reference65 articles.

1. Polycystic ovary syndrome;Franks;N Engl J Med,1995

2. Current concepts in the polycystic ovary syndrome;Dunaif;Annu Rev Med,2001

3. Correlation of hyperandrogenism with hyperinsulinemia in polycystic ovarian disease;Burghen;J Clin Endocrinol Metab,1980

4. Insulin resistance in nonobese patients with polycystic ovarian disease;Chang;J Clin Endocrinol Metab,1983

5. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 activity and serum androgens;Nestler;J Clin Endocrinol Metab,1997

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin beyond type 2 diabetes: Emerging and potential new indications;Diabetes, Obesity and Metabolism;2024-07-04

2. Correlation between anti-müllerian hormone in polycystic ovarian syndrome with metformin: a systematic review and meta-analysis;Gynecological Endocrinology;2024-04-13

3. Role of inflammation, oxidative stress, and angiogenesis in polycystic ovary syndrome (PCOS): Current perspectives;Targeting Angiogenesis, Inflammation, and Oxidative Stress in Chronic Diseases;2024

4. Polycystic Ovary Syndrome;Asian Journal of Pharmaceutical Research and Health Care;2023-10

5. Induced Pluripotent Stem Cells as a Possible Approach for Exploring the Pathophysiology of Polycystic Ovary Syndrome (PCOS);Stem Cell Reviews and Reports;2023-09-28